Article (Scientific journals)
Ribociclib plus Fulvestrant in Advanced Breast Cancer. Reply.
Slamon, Dennis J.; Jerusalem, Guy
2020In The New England journal of medicine, 382 (23), p. 85
Peer reviewed
 

Files


Full Text
Ribociclib plus fulvestrant in advanced breast cancer.pdf
Publisher postprint (59.07 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Aminopyridines; Breast Neoplasms; Fulvestrant; Humans; Purines; oncology
Disciplines :
Oncology
Author, co-author :
Slamon, Dennis J.
Jerusalem, Guy  ;  Université de Liège - ULiège > Département des sciences cliniques > Oncologie
Language :
English
Title :
Ribociclib plus Fulvestrant in Advanced Breast Cancer. Reply.
Publication date :
2020
Journal title :
The New England journal of medicine
ISSN :
0028-4793
eISSN :
1533-4406
Volume :
382
Issue :
23
Pages :
e85
Peer reviewed :
Peer reviewed
Available on ORBi :
since 10 November 2020

Statistics


Number of views
49 (2 by ULiège)
Number of downloads
2 (2 by ULiège)

Scopus citations®
 
1
Scopus citations®
without self-citations
1
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi